Obesity and age at diagnosis of endometrial cancer

Obstetrics and Gynecology

Volumn 124, Issue 2 PART1, 2014, Pages 300-306

  Nevadunsky, Nicole S ^a   Van Arsdale, Anne ^a   Strickler, Howard D ^a   Moadel, Alyson ^a   Kaur, Gurpreet ^a   Levitt, Joshua ^a   Girda, Eugenia ^a   Goldfinger, Mendel ^a   Goldberg, Gary L ^a   Einstein, Mark H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA, CLEAR CELL; AGE FACTORS; AGED; BODY MASS INDEX; CARCINOGENESIS; CARCINOMA, ENDOMETRIOID; CARCINOMA, PAPILLARY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; OBESITY; RETROSPECTIVE STUDIES;

EID: 84905100187     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000381     Document Type: Article

References (19)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10-7.
3. Schouten LJ, Goldbohm RA, Van den Brandt PA. Anthropometry, physical activity and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst 2004;96: 1635-8.
4. Renehan AG, Tyson M, Egger M, Heller R, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371:569-78.
5. Wartko P, Sherman M, Yang H, Felix A Brinton L, Trabert B. Recent changes in endometrial cancer trends among menopausal-age U.S. women. Cancer Epidemiol 2013;37: 374-7.
6. Key TJ, Pike MC. The dose-effect relationship between "unopposed" oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988;57:205-12.
7. Gunter M, Hoover D, Yu H, Wassertheil-Smoler S, Manson J, Li J, et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev 2008;17:921-9.
8. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000; 92:1472-89.
9. Pecorelli S, Benedet JL, Creasman WT, Shepherd JH. FIGO staging and gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gyne-cology and Obstetrics. Int J Gynecol Obstet 1999;64:5-10.
10. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992;55(suppl):615S-9S.
11. Vecchia C, Franceschi S, Decarli A, Gallus G, Tognoni G. Risk factors for endometrial cancer at different ages. J Natl Cancer Inst 1984;73:667-71.
12. Yang T, Claims B, Allen N, Sweetland S, Reeves G, Beral V; Million Women Study. Postmenopausal endometrial cancer and body size in early life and middle age: prospective cohort study. Br J Cancer 2012;107:169-75.
13. Ward K, Roncancio A, Shah N, Davis M, Saenz C, McHale M, et al. The risk of uterine malignancy is linearly associated with body mass index in a cohort of US women. Am J Obstet Gynecol 2013;209:579.e1-5.
14. Pellerin G, Finan M. Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. Am J Obstet Gyencol 2005;193:1640-4.
15. Lachance JA, Everett EN, Greer B, Mandel L, Swisher E, Ramimi H, et al. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endo-metrial cancer. Gynecol Oncol 2006;101:470-5.
16. Smotkin S, Nevadunsky N, Harris K, Einstein M, Yu Y, Goldberg GL. Histopathologic differences account for racial disparity in uterine cancer survival. Gynecol Oncol 2012;127:616-9.
17. Crosbie E, Roberts C, Qian W, Swart A, Kitchener H, Renehan A. Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from eh MRC ASTEC trial. Eur J Cancer 2012;48:853-64.
18. Gunter M, Hoover D, Yu H, Wassertheil-Smoller S, Rohan T, Manson JE, et al. Insulin, insulin-like growth factor-I, and risk for breast cancer in postmenopausal women. J Natl Cancer Inst 2009;101:48-60.
19. Barry J, Azizia M, Hardiman P. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2014. [Epub ahead of print].